1Eger EI II. A Brief History of the Origin of Minimum Alveolar Concentration (MAC) [J]. Anesthesiology, 2002, 96:238-239.
2Merkel G, Eger EI II. A comparative study of halothane and halopropane anesthesia: Including a method for determining equipotency [J]. Anesthesiology, 1963,24:346.
3Saidman LJ, Eger EI II. Effect of nitrous oxide and of narcotic premedication on the alveolar concentration of halothane required for anesthesia [J]. Anesthesiology, 1964, 25: 302-306.
4Eger EI II, Saidman LJ, Brandstater B. Minimum alveolar anesthetic concentration: A standard of anesthetic potency [J]. Anesthesiology, 1965, 26: 756-763.
5White D.Editorial: Uses of MAC [J]. Br J Anaesth, 2003, 91(2): 167-169.
6Eger EI II. Review. The pharmacology of isoflurane [J]. Br J Anesth, 1984, 56,71S-99S.
7Katoh T, Ikeda K. The minimum alveolar concentration (MAC) of sevoflurane in humans [J]. Anesthesiology, 1987, 66: 301-303.
8Dixon WJ. The up-and-down method for small samples[J]. J Am Statist Assoc, 1965, 60: 967-978.
9Gaumann DM. Mustaki JP, Tassonyi E. MAC-awake of isoflurane, enflurane and halothane evaluated by slow and fast alveolar washout [J]. Br J Anesth, 1992, 68:81-84.
10Eger EI II. Age, Minimum Alveolar Anesthetic Concentration, and Minimum Alveolar Concentration-Awake [J]. Anesth Analg, 2001, 93: 947-953.
6YANG X L,MA H X,YANG Z B,et al.Comparion of minimum alveolar concentration between intravenous isoflurane lipid emulsion and inhaled isoflurane in dogs[J].Anesthesiology,2006,104(3):482-487.
7NADESON R,GOODCHILD C S.Antinociceptive properties of propofol:involvement of spinal cord gamma-aminobutyric acid(A) receptors[J].J Pharmacol Exp Ther,1997,282(3):1181-1186.
8Mutoh T, Nishimura R, Kim H Y, et al. Cardiopulmonary effects of sevoflurane, compared with halo thane, enflurane, and isoflurane, in clogs [J]. Am J Vet Res, 1997, 58 (8): 885-890.
9Huang C.Method for the preparation of fluoromethyl-1,1,1,3,3,3-hexafluoro-2-propyl-ether:US,4874902[P].1989-10-17.
10Christopher Bieniarz,Kornepati V Ramakrishna.Method for synthesizing sevoflurane and an intermediate thereof:US,6,100,434[P].2002-08-08.
